OPEN END TURBO CALL-OPTIONSSCHEIN MIT SL - DEXCOM | Delayed Deutsche Boerse AG 18:55:11 13/05/2024 BST | ||
| 4.62 EUR | -2.74% |
|
| Current month | -3.46% | ||
| 1 month | -21.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
DEXCOM, INC.
Latest news about DEXCOM, INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/24 | 4.62 | -2.74% | 0 |
| 10/05/24 | 4.75 | -1.86% | 0 |
| 09/05/24 | 4.84 | +0.62% | 0 |
| 08/05/24 | 4.81 | -4.94% | 0 |
| 07/05/24 | 5.06 | +1.81% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 13, 2024 at 06:55 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | DEXCOM, INC. |
| Issuer | 
Société Générale
|
| WKN | SU2S0N |
| ISIN | DE000SU2S0N5 |
| Date issued | 27/11/2023 |
| Strike | 75.86 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.56 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.28 € |
|---|---|
| Lowest since issue | 3.56 € |
| Spread | 0.01 € |
| Spread % | 0.22% |
Company Profile
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals.
The United States accounts for 72.5% of net sales.
Sector
-
Consensus: DexCom, Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
127
USD
Average target price
150.9
USD
Spread / Average Target
+18.75%
- Stock Market
- Certificates
- Certificat
